Ignite Creation Date:
2024-05-05 @ 12:02 PM
Last Modification Date:
2024-10-26 @ 9:18 AM
Study NCT ID:
NCT00210314
Status:
COMPLETED
Last Update Posted:
2015-03-30
First Post:
2005-09-13
Brief Title:
Phase II Trial of Combined Modality Treatment in Primary Central Nervous System Lymphoma
Sponsor:
International Extranodal Lymphoma Study Group IELSG
Organization:
International Extranodal Lymphoma Study Group IELSG
Organization Data
Organization:
International Extranodal Lymphoma Study Group IELSG
Class:
OTHER
Study ID:
IELSG20
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
International Extranodal Lymphoma Study Group IELSG
Lead Sponsor Class:
OTHER
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
None
Responsible Party Affiliation:
None
Old Name:
International Extranodal Lymphoma Study Group IELSG
Old Organization:
IELSG